Free Trial
OTCMKTS:NUGS

Cannabis Strategic Ventures (NUGS) Stock Price, News & Analysis

Cannabis Strategic Ventures logo

About Cannabis Strategic Ventures Stock (OTCMKTS:NUGS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
449,750 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cannabis Strategic Ventures engages in the cultivation of marijuana products in the United States. It incubates, develops, and partners within the cannabis and ancillary sectors. The company is based in Los Angeles, California.

Receive NUGS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cannabis Strategic Ventures and its competitors with MarketBeat's FREE daily newsletter.

NUGS Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
Cannabis reduces blood vessel function by half
See More Headlines

NUGS Stock Analysis - Frequently Asked Questions

Shares of NUGS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cannabis Strategic Ventures investors own include Curaleaf (CURLF), Trulieve Cannabis (TCNNF), Tilray (TLRY), Aurora Cannabis (ACB), Canopy Growth (CGC), Cresco Labs (CRLBF) and Cronos Group (CRON).

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
OTCMKTS:NUGS
Fax
N/A
Employees
30
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (OTCMKTS:NUGS) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners